Aura Biosciences, Inc. — Director's Dealing 2021

Oct 28, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Aura Biosciences, Inc. (AURA)
CIK: 0001501796
Period of Report: 2021-10-28

Reporting Person: Primiano Christopher Brett (Chief Business Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$9.59	2031-09-22	Common Stock (124087)		Direct

Footnotes

F1: The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of September 20, 2021 with the remainder vesting in 36 substantially equal monthly instalments thereafter.